Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by langostaon Jan 12, 2022 5:00pm
556 Views
Post# 34310308

Is North America in the same situation

Is North America in the same situationFrom professor Karol Sikora former Director of WHO's Cancer Programme.

This from the UK, but can things be much better over here?

MPs from all parties lined up to set out in chilling terms the desperate situation we are now facing with cancer. In their words, it is a crisis in every shape and form.

Before Covid, the UK had a very poor record on cancer outcomes. Now the pandemic has devastated all recent efforts to improve cancer recovery and survival. Appointments cancelled, diagnostics delayed and treatment derailed. With cancer, delay costs lives.

The well-documented statistics are horrendous and anyone who thinks they will never be affected should remembers that cancer will affect 1 in every 2 of us at some stage in our lives.

Throughout the pandemic I have always tried to be as positive as possible but as someone who has spent 50 years treating cancer patients, I see the current situation in the gravest of terms.

Of all the medical backlogs grievously aggravated by the pandemic, cancer is the most time sensitive and time is running out fast.

<< Previous
Bullboard Posts
Next >>